Can-Fite BioPharma (CANF) Reports Q1 Loss of NIS0.21/Share

Can-Fite BioPharma (NYSE: CANF) reported Q1 EPS of (NIS0.21), versus (NIS0.06) reported last year. Revenue for the quarter came in at NIS214 thousand, versus NIS0 reported last year.

For earnings history and earnings-related data on Can-Fite BioPharma (CANF) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c